Developing a Core Set of Outcome Measures for Behcet Disease: Report from OMERACT 2016

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.44, sa.11, ss.1750-1753, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 11
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3899/jrheum.161352
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1750-1753
  • Anahtar Kelimeler: BEHCET DISEASE, OUTCOMES, OUTCOME MEASURES, OUTCOME ASSESSMENT, OMERACT, CONSTANT COMPARATIVE METHOD, CLINICAL-TRIALS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group has been working toward developing a data-driven core set of outcome measures for use in clinical trials of Behcet's syndrome [Behcet disease (BD)]. This paper summarizes the group's work through OMERACT 2016, discussions during the meeting, and the future research agenda.